Cardio-renal syndrome
MONDO:0044079A disorder of the heart and kidneys in which dysfunction of one of the organs induces dysfunction of the other organ.
Also known as: cardiorenal syndrome, Reno Cardiac syndrome, Reno-Cardiac syndrome, Reno-Cardiac syndromes, Renocardiac syndrome, Renocardiac syndromes, cardio renal syndrome, cardio-renal syndromes
38 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a common diabetes drug speed up heart and kidney healing?
Disease control CompletedThis study tests whether a diabetes drug called dapagliflozin can help people with heart failure who also develop kidney injury recover faster. About 30 adults will take the drug or usual care for three days. The main goal is to see if a larger trial is possible, not to prove the…
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Heart failure patients get better meds in special clinic
Disease control CompletedThis study tested whether a special clinic (GDMT Clinic) helps heart failure patients get the right medications compared to usual care. About 300 adults with heart failure took part over 12 weeks. The clinic aimed to improve medication use, health status, and heart function.
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Heart drug showdown: which works best when kidneys also fail?
Disease control CompletedThis completed study looked at 60 adults with acute decompensated heart failure and kidney impairment. Researchers compared three intravenous heart medications—levosimendan, dobutamine, and milrinone—to see which one improved heart and kidney function best. The goal was to find t…
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Heart failure drug use tracked in 13,660 remote monitoring patients
Knowledge-focused CompletedThis completed observational study looked at how often heart failure patients in a French nationwide remote monitoring program were prescribed SGLT2 inhibitors between 2021 and 2024. Researchers analyzed data from over 13,600 adults to see how prescription rates changed over time…
Sponsor: Satelia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Heart failure drug vericiguat under Real-World scrutiny in japan
Knowledge-focused CompletedThis study analyzed data from nearly 5,000 Japanese patients with chronic heart failure who started taking vericiguat as part of their regular care. Researchers tracked outcomes like hospital stays and deaths over one year to see how the drug performs in everyday practice. The go…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC